Vielh P - Search Results

1

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.

Ross K, Pailler E, Faugeroux V, Taylor M, Oulhen M, Auger N, Planchard D, Soria JC, Lindsay CR, Besse B, Vielh P, Farace F. Ross K, et al. Among authors: vielh p. Expert Rev Mol Diagn. 2015;15(12):1605-29. doi: 10.1586/14737159.2015.1111139. Epub 2015 Nov 13. Expert Rev Mol Diagn. 2015. PMID: 26564313 Review.

2

[Telomerase and cancer].

Soria JC, Ducray C, Vielh P. Soria JC, et al. Among authors: vielh p. Ann Pathol. 1998 Nov;18(5):391-403. Ann Pathol. 1998. PMID: 9864575 Review. French. No abstract available.

3

Telomerase activity in cancer: a magic bullet or a mirage?

Soria JC, Vielh P, el-Naggar AK. Soria JC, et al. Among authors: vielh p. Adv Anat Pathol. 1998 Mar;5(2):86-94. doi: 10.1097/00125480-199803000-00002. Adv Anat Pathol. 1998. PMID: 9868515 Review.

4

Quantitative fluorescence in situ hybridization in lung cancer as a diagnostic marker.

Truong K, Gerbault-Seureau M, Guilly MN, Vielh P, Zalcman G, Livartowski A, Chapelier A, Poupon MF, Dutrillaux B, Malfoy B. Truong K, et al. Among authors: vielh p. J Mol Diagn. 1999 Nov;1(1):33-7. doi: 10.1016/S1525-1578(10)60606-X. J Mol Diagn. 1999. PMID: 11272907 Free PMC article.

5

Molecular prognostic factors in resectable non-small cell lung cancer.

Vielh P, Spano JP, Grenier J, Le Chevalier T, Soria JC. Vielh P, et al. Crit Rev Oncol Hematol. 2005 Mar;53(3):193-7. doi: 10.1016/j.critrevonc.2004.10.007. Crit Rev Oncol Hematol. 2005. PMID: 15718145 Review.

6

[Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer].

de La Motte Rouge T, Valent A, Ambrosetti D, Vielh P, Lacroix L. de La Motte Rouge T, et al. Among authors: vielh p. Ann Pathol. 2007 Oct;27(5):353-63. doi: 10.1016/s0242-6498(07)78274-3. Ann Pathol. 2007. PMID: 18185470 French.

7

Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.

Jacques N, Vimond N, Conforti R, Griscelli F, Lecluse Y, Laplanche A, Malka D, Vielh P, Farace F. Jacques N, et al. Among authors: vielh p. J Immunol Methods. 2008 Sep 15;337(2):132-43. doi: 10.1016/j.jim.2008.07.006. Epub 2008 Jul 26. J Immunol Methods. 2008. PMID: 18662694

8

[Anti-apoptotic mechanisms in small-cell lung carcinoma].

Loriot Y, Calderaro J, Soria JC, Deutsch E, Vielh P. Loriot Y, et al. Among authors: vielh p. Ann Pathol. 2010 Feb;30(1):17-24. doi: 10.1016/j.annpat.2009.12.005. Epub 2010 Feb 20. Ann Pathol. 2010. PMID: 20223350 French.

9

Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.

Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Poudenx M, Sibon S, Kelhef S, Vénissac N, Jais JP, Mouroux J, Molina TJ, Hofman P. Hofman V, et al. Among authors: vielh p. Clin Cancer Res. 2011 Feb 15;17(4):827-35. doi: 10.1158/1078-0432.CCR-10-0445. Epub 2010 Nov 23. Clin Cancer Res. 2011. PMID: 21098695

10

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, Molina T, Vénissac N, Mouroux J, Vielh P, Hofman P. Hofman V, et al. Among authors: vielh p. Int J Cancer. 2011 Oct 1;129(7):1651-60. doi: 10.1002/ijc.25819. Epub 2011 Mar 11. Int J Cancer. 2011. PMID: 21128227 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page